Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0680
+0.0030 (4.62%)
At close: Mar 3, 2026
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 20.89 million as of March 3, 2026. Its market cap has decreased by -17.83% in one year.
Market Cap
20.89M
Enterprise Value
25.05M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 20.89M, an increase of 50.23%. That is a compound annual growth rate of 4.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 20.89M | -23.13% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avecho Biotechnology | 36.73M |
| NeuroScientific Biopharmaceuticals | 33.26M |
| Argenica Therapeutics | 28.90M |
| Algorae Pharmaceuticals | 27.33M |
| Patrys | 20.88M |
| Neurotech International | 16.85M |
| AdAlta | 10.20M |
| Bio-Gene Technology | 10.07M |